Dual Versus Never Use of E-Cigarettes Among American Indians Who Smoke.

Dorothy A Rhoades, Ashley L Comiford, Justin D Dvorak, Kai Ding, Leslie M Driskill, Audrea M Hopkins, Paul Spicer, Theodore L Wagener, Mark P Doescher
Author Information
  1. Dorothy A Rhoades: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Stephenson Cancer Center, Oklahoma City, Oklahoma. Electronic address: dorothy-rhoades@ouhsc.edu.
  2. Ashley L Comiford: Epidemiology, Cherokee Nation, Tahlequah, Oklahoma.
  3. Justin D Dvorak: College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  4. Kai Ding: College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  5. Leslie M Driskill: Oklahoma Tobacco Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  6. Audrea M Hopkins: College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  7. Paul Spicer: Center for Applied Social Research, University of Oklahoma, Norman, Oklahoma.
  8. Theodore L Wagener: Oklahoma Tobacco Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  9. Mark P Doescher: Stephenson Cancer Center, Oklahoma City, Oklahoma; Department of Family Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

Abstract

INTRODUCTION: Many American Indian communities have a high prevalence of smoking and e-cigarette use, but factors associated with their dual use are rarely studied.
METHODS: In 2016, a total of 375 American Indian adults who smoke completed paper surveys regarding cigarette and e-cigarette use and provided saliva for cotinine levels. In 2018, cross-sectional analyses were performed, comparing dual users (12%), defined as using e-cigarettes on some or every day for the past 30 days, with never users of e-cigarettes (37%).
RESULTS: Compared with never users, dual users were younger, more often reported history of depression (56% and 29%, respectively; p<0.01) and family history of smoking-related disease (77% and 59%, respectively; p<0.05), had lower harm perceptions of e-cigarettes (27% and 47%, respectively; p<0.01) or vapor (14% and 35%, respectively; p<0.01), and more often perceived e-cigarettes as cessation aids (75% and 16%, respectively; p<0.01) and as less harmful than cigarettes (70% and 17%, respectively; p<0.01). Dual users were less often uncertain/unknowing about e-cigarette benefits or harms (p<0.01) and more often reported likelihood to quit smoking (49% and 24%, respectively; p<0.01) and prior attempt to quit smoking, ever (89% and 67%, respectively; p<0.01) or in the past year (55% and 32%, respectively; p=0.01). Cigarette consumption and cotinine levels did not differ between groups. Dual users more often tried other nicotine products (p<0.02) and more often lived with a vaping partner/spouse (45% and 6%, respectively; p<0.01).
CONCLUSIONS: Dual users perceived e-cigarettes as less harmful than cigarettes and more as cessation aids than cigarette-only users did, but cigarette consumption did not differ between groups. Whether e-cigarettes will reduce smoking-related disparities among American Indian people remains undetermined.

References

  1. Am J Public Health. 2014 Jun;104 Suppl 3:S481-9 [PMID: 24754662]
  2. Tob Control. 2019 Jan;28(1):42-49 [PMID: 29574448]
  3. MMWR Suppl. 2013 Nov 22;62(3):81-4 [PMID: 24264495]
  4. Int J Circumpolar Health. 2015 Oct 19;74:27794 [PMID: 26487575]
  5. PLoS One. 2016 Nov 18;11(11):e0165938 [PMID: 27861501]
  6. MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211 [PMID: 27832052]
  7. Nicotine Tob Res. 2015 Feb;17(2):127-33 [PMID: 25301815]
  8. Nicotine Tob Res. 2016 May;18(5):715-9 [PMID: 26525063]
  9. BMJ. 2017 Jul 26;358:j3262 [PMID: 28747333]
  10. Prev Med. 2016 Dec;93:14-20 [PMID: 27612572]
  11. Am J Med Sci. 2016 Oct;352(4):420-426 [PMID: 27776725]
  12. Drug Alcohol Depend. 2017 Apr 01;173:139-143 [PMID: 28246049]
  13. Lancet. 2013 Nov 16;382(9905):1629-37 [PMID: 24029165]
  14. Nicotine Tob Res. 2015 Oct;17(10):1195-202 [PMID: 25381306]
  15. Nicotine Tob Res. 2016 Jan;18(1):41-7 [PMID: 25744953]
  16. Nicotine Tob Res. 2014 Jun;16(6):672-81 [PMID: 24376276]
  17. NCHS Data Brief. 2015 Oct;(217):1-8 [PMID: 26555932]
  18. Drug Alcohol Depend. 2017 Jan 01;170:93-101 [PMID: 27883949]
  19. Am J Prev Med. 2015 Nov;49(5):738-744 [PMID: 26163166]
  20. Psychiatr Serv. 1998 Mar;49(3):345-50 [PMID: 9525794]
  21. Prev Med. 2014 May;62:14-9 [PMID: 24440684]
  22. J Am Heart Assoc. 2018 Apr 26;7(9): [PMID: 29700041]
  23. Ann Intern Med. 2017 Mar 21;166(6):390-400 [PMID: 28166548]
  24. Am J Public Health. 2012 Sep;102(9):1758-66 [PMID: 22813087]
  25. Nicotine Tob Res. 2014 Jan;16(1):108-14 [PMID: 24154511]
  26. Tob Control. 2015 Sep;24(5):442-8 [PMID: 24935441]
  27. Am J Prev Med. 2017 Feb;52(2):e33-e66 [PMID: 27914771]
  28. Public Health Rep. 2005 Mar-Apr;120(2):192-9 [PMID: 15842122]
  29. Tob Control. 2005 Oct;14(5):315-20 [PMID: 16183982]
  30. Open J Prev Med. 2014 Oct;4(10):789-800 [PMID: 25621193]
  31. Cancer Prev Res (Phila). 2015 Sep;8(9):873-8 [PMID: 26333731]
  32. Am J Prev Med. 2016 Jun;50(6):709-718 [PMID: 26711162]
  33. Addict Behav. 1997 Mar-Apr;22(2):207-18 [PMID: 9113215]
  34. Prev Med. 2017 Nov;104:92-99 [PMID: 28729198]
  35. Addict Sci Clin Pract. 2012 Jun 08;7:8 [PMID: 23186265]
  36. Am J Health Behav. 2015 Mar;39(2):277-84 [PMID: 25564840]
  37. Nicotine Tob Res. 2005 Feb;7(1):157-61 [PMID: 15804688]
  38. Nicotine Tob Res. 2014 Nov;16(11):1512-7 [PMID: 24827786]
  39. Ethn Dis. 2006 Winter;16(1):35-40 [PMID: 16599346]
  40. Am J Prev Med. 2019 Jan;56(1):167-178 [PMID: 30573147]
  41. N Engl J Med. 2016 Apr 7;374(14):1301-3 [PMID: 27050203]
  42. Am J Prev Med. 2014 Aug;47(2):141-9 [PMID: 24794422]
  43. PLoS One. 2015 Jun 10;10(6):e0129443 [PMID: 26061661]
  44. Acad Pediatr. 2018 Nov - Dec;18(8):920-927 [PMID: 29653256]
  45. Am J Prev Med. 2014 Oct;47(4):505-7 [PMID: 25092121]
  46. J Community Health. 2013 Jun;38(3):538-45 [PMID: 23338849]
  47. Addict Behav. 2018 Sep;84:69-74 [PMID: 29627636]
  48. Am J Prev Med. 2014 Oct;47(4):476-80 [PMID: 24880986]
  49. J Am Assoc Nurse Pract. 2016 Sep;28(9):510-5 [PMID: 26997487]
  50. Nicotine Tob Res. 2016 Nov;18(11):2124-2129 [PMID: 27613942]
  51. Addiction. 2015 Jul;110(7):1160-8 [PMID: 25900312]
  52. Am J Public Health. 2013 Sep;103(9):e57-62 [PMID: 23865700]
  53. Am J Med. 2018 Mar;131(3):318.e1-318.e8 [PMID: 29024622]
  54. Addict Behav. 2016 Nov;62:145-51 [PMID: 27376882]
  55. MMWR Morb Mortal Wkly Rep. 2016 Aug 05;65(30):753-8 [PMID: 27491017]
  56. Soc Psychiatry Psychiatr Epidemiol. 2018 May;53(5):521-530 [PMID: 29470596]
  57. Nicotine Tob Res. 2015 Feb;17(2):186-92 [PMID: 25332459]
  58. Int J Environ Res Public Health. 2017 Oct 11;14(10): [PMID: 29019917]
  59. Am J Prev Med. 2017 Nov;53(5):652-660 [PMID: 28864130]
  60. Am J Public Health. 2015 Jun;105(6):1213-9 [PMID: 25880947]
  61. Prev Chronic Dis. 2010 Mar;7(2):A29 [PMID: 20158957]
  62. Tob Control. 2016 Apr;25(e1):e24-9 [PMID: 26085124]
  63. Br J Addict. 1989 Jul;84(7):791-9 [PMID: 2758152]
  64. Am J Health Behav. 2018 Nov 1;42(6):101-109 [PMID: 30158005]
  65. Nicotine Tob Res. 2015 Sep;17(9):1085-95 [PMID: 25385875]
  66. BMJ Open. 2017 Dec 19;7(12):e018469 [PMID: 29259060]
  67. Addict Behav. 2014 Jun;39(6):1120-5 [PMID: 24679611]
  68. Nicotine Tob Res. 2015 Oct;17(10):1228-34 [PMID: 25589678]
  69. Am J Public Health. 2014 Aug;104(8):1437-44 [PMID: 24922154]
  70. Nicotine Tob Res. 2015 Dec;17(12):1473-81 [PMID: 25634932]
  71. Eur J Epidemiol. 2015 Jul;30(7):553-61 [PMID: 25968176]
  72. N Engl J Med. 2017 Jan 26;376(4):342-353 [PMID: 28121512]
  73. Nicotine Tob Res. 2016 Mar;18(3):259-66 [PMID: 25847288]
  74. BMJ. 2015 Sep 21;351:h4065 [PMID: 26391240]
  75. Lancet Respir Med. 2016 Feb;4(2):116-28 [PMID: 26776875]
  76. Psychol Med. 2005 Dec;35(12):1785-94 [PMID: 16300692]
  77. JAMA Intern Med. 2014 May;174(5):812-3 [PMID: 24664434]

Grants

  1. P20 CA202921/NCI NIH HHS
  2. P20 CA202923/NCI NIH HHS
  3. P30 CA225520/NCI NIH HHS
  4. U54 GM104938/NIGMS NIH HHS

MeSH Term

Adolescent
Adult
Age Factors
Cotinine
Cross-Sectional Studies
Electronic Nicotine Delivery Systems
Female
Humans
Indians, North American
Male
Middle Aged
Prevalence
Saliva
Smoking Cessation
Tobacco Smoking
Vaping
Young Adult

Chemicals

Cotinine

Word Cloud

Created with Highcharts 10.0.0p<0respectively01userse-cigarettesoftenAmericanDualIndiansmokinge-cigaretteuseduallesscigarettecotininelevelspastneverreportedhistorysmoking-relatedperceivedcessationaidsharmfulcigarettesquitconsumptiondiffergroupsINTRODUCTION:ManycommunitieshighprevalencefactorsassociatedrarelystudiedMETHODS:2016total375adultssmokecompletedpapersurveysregardingprovidedsaliva2018cross-sectionalanalysesperformedcomparing12%definedusingeveryday30days37%RESULTS:Comparedyoungerdepression56%29%familydisease77%59%05lowerharmperceptions27%47%vapor14%35%75%16%70%17%uncertain/unknowingbenefitsharmslikelihood49%24%priorattemptever89%67%year55%32%p=0Cigarettetriednicotineproducts02livedvapingpartner/spouse45%6%CONCLUSIONS:cigarette-onlyWhetherwillreducedisparitiesamongpeopleremainsundeterminedVersusNeverUseE-CigarettesAmongIndiansSmoke

Similar Articles

Cited By